A Double Blind, Parallel-group, Randomized Placebo Controlled, Multicentre Exploratory Study of Dimiracetam in Treatment Induced Painful Neuropathy in Patients With HIV Infection.
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2011
At a glance
- Drugs Dimiracetam (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- 17 Aug 2011 New trial record
- 21 Oct 2010 Interim results were reported in a Neurotune Media Release.